ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195,905 | +640.7% | 9,561 | +618.3% | 0.00% | – |
| Q2 2023 | $26,447 | +26.8% | 1,331 | +9.3% | 0.00% | – |
| Q1 2023 | $20,864 | -10.3% | 1,218 | +2.5% | 0.00% | – |
| Q4 2022 | $23,249 | +16.2% | 1,188 | -7.1% | 0.00% | – |
| Q3 2022 | $20,000 | -9.1% | 1,279 | -21.3% | 0.00% | – |
| Q2 2022 | $22,000 | -86.6% | 1,625 | -84.2% | 0.00% | – |
| Q1 2022 | $164,000 | -17.6% | 10,284 | +12.6% | 0.00% | – |
| Q4 2021 | $199,000 | -14.6% | 9,134 | +17.3% | 0.00% | – |
| Q3 2021 | $233,000 | -10.7% | 7,790 | +32.3% | 0.00% | – |
| Q2 2021 | $261,000 | +16.0% | 5,888 | +16.0% | 0.00% | – |
| Q1 2021 | $225,000 | +1507.1% | 5,077 | +1891.0% | 0.00% | – |
| Q4 2020 | $14,000 | +366.7% | 255 | +125.7% | 0.00% | – |
| Q3 2020 | $3,000 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |